LDC’s investment and support will help us further improve our proposition, enabling our clients to maintain the best practices and professional standards in medicines management and the highest quality of patient care.”Yachna Tak, CEO
Enhancing a market-leading business
In March 2020, LDC backed the business’ experienced management team of Chief Executive Officer Yachna Tak, Chief Pharmacist Martin England, and Financial Director Keith Hersee.
LDC’s investment is supporting the business’ growth strategy, as it continues to develop its infrastructure and distribution network, and enhance its technology platform.
In December 2021, the business acquired Firza, an experienced provider of clinical pharmacy services to support primary care providers in the UK. The acquisition allows Ashtons to offer a wider range of healthcare providers unparalleled services and software solutions across both primary and secondary care.
Read our ‘Ask the CEO’ brochure where we asked CEO of Ashtons Yachna Tak on why she chose private equity investment for her business and how she has safeguarded employees and customers in the COVID-19 pandemic.